Delivery Order SPE2DB20D9331-SPE2DB25FL1S1
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by August 20, 2025, and represents performance at the contractor's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,434.34 by the Defense Logistics Agency on July 30, 2025, for the supply of Cabometyx 60 mg tablets (30-count units). The delivery order is issued without a set-aside designation and is scheduled for completion by July 31, 2025. This award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency (DLA) for the supply of Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $91,598.40 contract is for the delivery of Cabometyx 20 mg tablets to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- The Department of Defense (DoD) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $15,409.02, is for the delivery of Cabometyx 40 mg tablets to meet the recurring pharmaceutical supply needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA)...
- The U.S. Defense Logistics Agency (DLA) awarded a $30,818.04 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of CABOMETYX 40 mg tablet bottles, with a period of performance through April 11, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued at up to $4,999,999, which allows the agency to issue delivery orders for a broad range of...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $45,519.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of CABOMETYX 60 MG TABLET 30S to support the recurring pharmaceutical needs of military health facilities. This order is part of a larger single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $15,221.97 under an indefinite delivery contract with the Defense Logistics Agency to supply Cabometyx 40 mg tablets. As a woman-owned small business, DMS Pharmaceutical Group will deliver 30 tablets of Cabometyx to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical by November 9, 2023. DMS Pharmaceutical Group currently supplies pharmaceuticals and medical products in...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical drug CABOMETYX 20 MG TABLET 30S. The total potential value of the order is $15,596.22, with a completion date of January 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that supplies a wide range of pharmaceutical and medical products to the federal government, particularly the Department of Defense,...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1S1Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $83,162.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This delivery order was issued without a set-aside designation on August 11, 2025, with an ultimate completion date of August 12, 2025. The award represents a discrete purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense medical facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets. The company's portfolio includes branded and generic prescription medications, biologics, over-the-counter products, and medical consumables, with delivery orders covering oncology treatments, specialty injections, vaccines, and other pharmaceutical items. Cabometyx, a targeted cancer therapy, aligns with the company's demonstrated capability in supplying specialized pharmaceutical products to military health facilities across the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $83.2k | 8/11/25 |